Loading...
VMAR is not a good buy right now for an impatient trader. The stock is in a clear downtrend (bearish moving averages) and is breaking below key support (S1 3.414) with weak momentum. Even though it is extremely oversold (RSI~18) and could bounce, there is no Intellectia buy signal and the risk of further downside toward ~2.73 is high. Best action now is to avoid/exit rather than buy immediately.
Price action/Trend: Strong bearish trend with SMA_200 > SMA_20 > SMA_5, confirming sustained downside pressure. Momentum: RSI_6 at ~18 signals deeply oversold (bounce potential), but oversold alone is not a buy trigger in a strong downtrend. MACD: Histogram positive (0.89) but 'positively contracting' suggests bullish momentum is fading rather than accelerating. Levels: Pivot 4.518 (far overhead). Support: S1 3.414 has been broken (current 3.23), next key support S2 2.732. Resistance: reclaiming 3.414 is first step; larger resistance at 4.518.
Intellectia Proprietary Trading Signals
Pattern-based odds (provided): 60% chance of small upside (+1.14% next day), but that is modest versus the downside risk while below support.
raises the probability of a short-term technical bounce. Financial snapshot shows a sharp YoY revenue increase in 2026/Q1 (likely influenced by a low base). No heavy hedge fund or insider activity flagged (neutral), which avoids an added negative signal.
Post/Pre-market weakness reinforces selling pressure. Fundamentals also show pressure: EPS worsened YoY and gross margin dropped sharply, and net income is still negative. No news in the last week means no clear near-term catalyst to reverse sentiment. Congress trading: no recent data available (no supportive signal).
Latest quarter: 2026/Q1. Revenue rose to 15,692,844 (+15,253.53% YoY), but profitability remains weak: net income is still negative (-4,312,549) despite improving YoY. EPS fell to -5.46 (worse YoY), and gross margin declined to 33.43 (reported as down materially YoY). Overall: headline revenue growth is strong, but margin/EPS trends are not supportive of a confident immediate long entry.
No analyst rating or price target change data was provided, so a Wall Street pro/con consensus cannot be confirmed from this dataset. Based on the available data only: pros would be revenue acceleration; cons are ongoing losses, weaker EPS/margins, and a clearly bearish chart.
